Kevin C. Tang
2018
In 2018, Kevin C. Tang earned a total compensation of $1 as Chairman and Chief Executive Officer at Odonate Therapeutics, which was the same as previous year.
Compensation breakdown
| Salary | $1 |
|---|---|
| Total | $1 |
Tang received $1 in salary, accounting for 100% of the total pay in 2018.
Rankings
In 2018, Kevin C. Tang's compensation ranked 14,244th out of 14,244 executives tracked by ExecPay.
| Classification | Ranking | Percentile |
|---|---|---|
All | 14,244 out of 14,244 | 0th |
Division Manufacturing | 5,763 out of 5,765 | 0th |
Major group Chemicals And Allied Products | 2,128 out of 2,128 | 0th |
Industry group Drugs | 1,817 out of 1,817 | 0th |
Industry Pharmaceutical Preparations | 1,391 out of 1,391 | 0th |
Source: SEC filing on June 24, 2019.
Tang's colleagues
We found two more compensation records of executives who worked with Kevin C. Tang at Odonate Therapeutics in 2018.
News
Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2020 pay falls 31% to $1.4M
June 1, 2021
Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2019 pay jumps 37% to $2M
May 15, 2020
Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2018 pay jumps 465% to $1.4M
June 24, 2019